Innoscripta (1INN) Q4 2024 earnings summary

Executive summary

• Audit confirmed the consolidated financial statements present a true and fair view of the group's assets, financial, and earnings position as of December 31, 2024, in accordance with German GAAP.

• No objections were raised regarding the regularity of the consolidated financial statements; an unqualified audit opinion was issued.

• The group voluntarily prepared consolidated financial statements, as not legally required.

Financial highlights

• Revenue increased to €64.7 million for 2024, up from €39.4 million in 2023.

• Consolidated net income after taxes rose to €25.1 million, compared to €10.3 million in the prior year.

• Cash flow from operating activities reached €20.1 million, up from €5.3 million year-over-year.

• Dividend of €8 million was distributed from the 2023 profit; proposed 2024 dividend is €2.40 per share.

• Equity increased to €35.1 million as of year-end 2024, from €18.1 million at the end of 2023.

Outlook and guidance

• No significant events after the balance sheet date; no forward-looking risks or uncertainties identified.

• Board proposes a dividend payout and plans to carry forward €141,951.13 to new account.